Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases - An initial case study

Research in Veterinary Science

Volumn 84, Issue 3, 2008, Pages 347-353

  Fietz, S ^a   Bondzio, A ^a   Moschos, A ^a   Hertsch, B ^a   Einspanier, R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Equine myeloperoxidase; Neutrophil; O dianisidine assay; Septic arthritis; Synovial fluid

Indexed keywords

4 AMINOBENZOHYDRAZIDE; 4 AMINOBENZOIC ACID DERIVATIVE; DIANISIDINE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL HEALTH; ARTHRITIS; ARTHROPATHY; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; HORSE; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; REPRODUCIBILITY; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS; ARTHRITIS, INFECTIOUS; HORSE DISEASES; HORSES; JOINT DISEASES; KINETICS; KNEE JOINT; OSTEOARTHRITIS; PEROXIDASE; REFERENCE VALUES; SYNOVIAL FLUID;

EQUIDAE;

EID: 41749102395     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.06.006     Document Type: Article

References (44)

1. Bertone A.L., Palmer J.L., and Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet. Surg. 30 (2001) 528-538
2. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78 (1982) 206-209
3. Brama P.A.J., van den Boom R., DeGroot J., Kiers G.H., and van Weeren P.R. Collagenase-1 (MMP- 1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis. Equine Vet. J. 36 (2004) 34-40
4. Bretz U., and Baggliolini M. Biochemical and morphological characterization of azurophilic and specific granules of human neutrophilic polymorphonuclear leukocytes. J. Cell Biol. 63 (1974) 251-269
5. Brown J.F., Chang Q., Soper B.D., and Tepperman B.L. Protein kinase C mediates experimental colitis in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 276 (1999) G583-G590
6. Burner U., Obinger C., Paumann M., Furtmüller P.G., and Kettle A.J. Transient and steady-state kinetics of the oxidation of substituted benzoic acid hydrazides by myeloperoxidase. J. Biol. Chem. 274 (1999) 9494-9502
7. Clegg P.D., Coughlan A.R., Riggs C.M., and Carter S.D. Matrix metalloproteinase 2 and 9 in equine synovial fluids. Equine Vet. J. 29 (1997) 343-348
8. Davies E.V., Williams B.D., and Campbell A.K. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO and NADPH-oxidase activity. Brit. J. Rheumatol. 29 (1990) 415-421
9. 2-macroglobulin by activated human polymorphonuclear leukocytes. Med. Inflamm. 3 (1994) 117-123
10. Deby-Dupont G., Grülke S., Caudron I., Mathy-Hartert M., Benbarek H., Deby C., Lamy M., and Serteyn D. Equine neutrophil myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies. Vet. Immunol. Immunopathol. 66 (1998) 257-271
11. Dieppe P.A., Crocker R.P., Corke C.F., Doyle D.V., Huskisson E.C., and Willoughby D.A. Synovial fluid crystals. Quart. J. Med. 48 (1979) 533-553
12. De Mendez I., Young Jr. K.R., Bignon J., and Lambré C.R. Biochemical characteristics of alveolar macrophage-specific peroxidase activities in the rat. Arch. Biochem. Biophys. 289 (1991) 319-323
13. Edwards S.W., Hughes V., Barlow J., and Bucknall R. Immunological detection of myeloperoxidase in synovial fluids from patients with rheumatoid arthritis. Biochem. J. 250 (1988) 81-85
14. Ekman S., Skiöldebrand E., Heinegard D., and Hultenby K. Ultrastructural immunolocalisation of bones sialoprotein in the osteocartilagenous interface of the equine third carpal bone. Equine Vet. J. 37 (2005) 26-30
15. Frisbie D.D., Ray C.S., Ionescu M., Poole A.R., Chapman P.L., and McIlwraith C.W. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am. J. Vet. Res. 60 (1999) 306-309
16. Fuller C.J., Barr A.R., Sharif M., and Dieppe P.A. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthr. Cart. 9 (2001) 49-55
17. Gibson K.T., Hodge H., and Whittem T. Inflammatory mediators in equine synovial fluid. Aust. Vet. J. 73 (1996) 148-151
18. Green S.P., Baker M.S., and Lowther D.A. Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex. J. Rheumatol. 17 (1990) 1670-1675
19. Hasselbacher P. Variation in synovial fluid analysis by hospital laboratories. Arthritis Rheum. 30 (1987) 637-642
20. Jerlich A., Fritz G., Kharrazi H., Hammel M., Tschabuschnig S., Glatter O., and Schaur R.J. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation. Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol. 1481 (2000) 109-118
21. Kettle A.J., Gedye C.A., Hampton M.B., and Winterbourn C.C. Inhibition of myeloperoxidase by benzoic acid hydrazides. Biochem. J. 308 (1995) 559-563
22. Klebanoff S.J. Oxygen metabolites from phagocytes. In: Gallin I.M., Goldstein J.I., and Snyderman M.D. (Eds). Inflammation: Basic Principles and Clinical Correlates (1992), Raven Press, New York 391-444
23. Kumar P., Pai K., Pandey H.P., and Sundar S. NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. J. Med. Microbiol. 51 (2002) 832-836
24. Lammer, B., 2001. Examination of synovial fluid parameters from dogs with osteoarthritis with a special attention to the myeloperoxidase content. Dissertation, Clinic of Small Animals, FU-Berlin.
25. Li S.F., Cassidy C., Chang C., Gharib S., and Torres J. Diagnostic utility of laboratory tests in septic arthritis. Emerg. Med. J. 24 (2007) 75-77
26. Litzke L.F. Erkrankungen der Gelenke. In: Dietz O., and Litzke L.F. (Eds). Lehrbuch der Allgemeinen Chirurgie für Tiermediziner. sixth ed. (2004), Enke-Verlag, Stuttgart, Germany 229-271
27. Mathews C.J., Kingsley G., Field M., Jones A., Weston V.C., Phillips M., Walker D., and Coakley G. Management of septic arthritis - a systematic review. Ann. Rheum. Dis. 66 (2007) 440-445
28. McConnico R.S., Weinstock D., Poston M.E., and Roberts M.C. Myeloperoxidase activity of the large intestine in an equine model of acute colitis. Am. J. Vet. Res. 60 (1999) 807-813
29. McIlwraith C.W., Billinghurst R.C., and Frisbie D.D. Current and future diagnostic means to better characterize osteoarthritis in the horse - routine synovial fluid analysis and synovial fluid and serum markers. AAEP Proc. 47 (2001) 171-179
30. McIlwraith C.W. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review. Equine Vet. J. 37 (2005) 473-482
31. 2 system by synovial fluid isolated from patients with rheumatoid arthritis. Ann. Rheum. Dis. 50 (1991) 237-242
32. Persson L. On the synovia in horses. A clinical and experimental study. Acta Vet. Scand. Suppl. 35 (1971) 3-77
33. Rosen H., and Klebanoff S.J. Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J. Biol. Chem. 252 (1977) 4803-4810
34. Salinas M., Rosas J., Iborra J., Manero H., and Pascual E. Comparison of manual and automated cell counts in EDTA preserved synovial fluids. Storage has little influence on the results. Ann. Rheum. Dis. 56 (1997) 622-626
35. Sander, T. 1990. Synovial fluid analysis-particularly the determination of hyaluronic acid from the tibiotarsal joint with chips and after arthroscopy. Dissertation, Tierärztliche Hochschule Hannover.
36. Schiller J., Arnhold J., Sonntag K., and Arnold K. NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid. Man. Res. Med. 35 (1996) 848-853
37. Schultz J., and Kaminker K. Myeloperoxidase of the leukocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys. 96 (1962) 465-467
38. Spellmeyer, K., 2003. Myeloperoxidase activity in serum and synovia in dogs with osteoarthritis. A prospective study. Dissertation, Clinic of Small Animals, FU-Berlin.
39. Spellmeyer, K., Lemansky, P., Hasilik, A., Brunnberg, L., 2003. Myeloperoxidase-konzentration in Serum und in der Synovia bei Hunden mit Osteoarthritis. Deutsche Veterinärmedizinische Gesellschaft/12. Jahrestagung der Fachgruppe Innere Medizin und Klinische Labordiagnostik, Gießen, Germany, pp. 89-90.
40. Swan A., Amer H., and Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease: a literature survey. Ann. Rheum. Dis. 61 (2002) 493-498
41. Tercic D., and Bozic B. The basis of the synovial fluid analysis. Clin. Chem. Lab. Med. 39 (2001) 1221-1226
42. Vincent J., Korn J.H., Podewell C., and Tully E. Synovial fluid pseudoleukocytosis. Arthritis Rheum. 23 (1980) 1399-1400
43. Winterbourn C.C., Vissers M.C.M., and Kettle A.J. Myeloperoxidase. Curr. Opin. Hematol. 7 (2000) 53-58
44. Xia Y., and Zweier J.L. Measurement of myeloperoxidase in leucocyte-containing tissues. Anal. Biochem. 245 (1997) 93-96